Table 1 Participants’ demographics and patients medical characteristics (n = 272)
Participants’ demographics | No. (%) | |
Nationality (Dutch) | 271 (99.6%) | |
Gender | Man | 265 (97.4%) |
Women | 7 (2.6%) | |
Gender patient | Women | 270 (99.3%) |
Man | 2 (0.7%) | |
Age, mean (SD), years (n = 271) | 61.4 (10,6) | |
Married and/or cohabited | 265 (97.4%) | |
Duration of the relationship | 1–5 years | 10 (3.7%) |
6–10 years | 12 (4.4%) | |
11–20 years | 34 (12.5%) | |
> 20 years | 216 (79.4%) | |
Children | Yes, living independently | 155 (57%) |
Yes, living at home | 77 (28.3) | |
No | 37 (13.6) | |
No, but a desire to have children | 3 (1.1) | |
Educationa, mean (SD) (n = 271) | 4.99 (1.4) | |
Occupationb (n = 271) | Paid work | 141 (52%) |
Retirement | 114 (42.1%) | |
Disablement insurance act or sick leave | 12 (4.4%) | |
Other | 21 (7.7%) 7,7 | |
Type of hospital | General hospitals | 142 (52,2%) |
University hospitals | 130 (47,8%) | |
Medical characteristics of the patients | No. (%) | |
Time since diagnosis (n = 272) | In the last month | 2 (0.7%), 7 |
1–6 months | 50 (18.4%) | |
6–12 months | 65 (23.9%) | |
1–2 year | 83 (30.5%) | |
2–5 year | 72 (26.5%) | |
Received treatment (n = 270) | Radiotherapy (RT) | 171 (63.3%) 63,3 |
Chemotherapy (CT) | 131 (48.5%) 48,5 | |
Immunotherapy (IT) | 12 (4.4%) 4,4 | |
Hormonal therapy (HT) | 3 (1.1%) 1,1 | |
No addition therapy finished | 44 (16.3%) 16,3 | |
Current treatment (n = 270) | (RT or CT or IT or HT) | 159 (58.9%) 58,9 |
(RT or CT or IT) | 46 (17%) 17,0 | |
(RT or CT) | 36 (13.3%) 13,3 | |